In 2023, the hospital discharges for Leiomyoma of Uterus in Italy stood at approximately 34.0 thousand. Forecasted data from 2024 to 2028 shows a consistent year-over-year decline in discharges, starting from 33.19 thousand in 2024 to 30.6 thousand by 2028. This indicates a downward trend with annual reductions, averaging a Compound Annual Growth Rate (CAGR) of approximately -2% over the forecasted period.

Future trends to watch for include:

Technological advancements in non-invasive procedures could further reduce hospital discharges.
An increase in awareness and access to alternative therapies might impact future discharge rates.
Policy changes in healthcare could also affect the trend.